Huang Linna, He Hangyong, Jin Jingjing, Zhan Qingyuan
Department of Pulmonary and Critical Care Medicine, Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, People's Republic of China.
Beijing Institute of Respiratory Medicine, Department of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.
BMC Infect Dis. 2017 Mar 14;17(1):209. doi: 10.1186/s12879-017-2307-y.
Three diagnostic criteria have been proposed used for invasive pulmonary aspergillosis (IPA) diagnosis, namely EORTC/ MSG criteria, Bulpa criteria and intensive care unit (ICU) criteria. The Bulpa criteria were proposed to diagnose IPA in chronic obstructive pulmonary disease (COPD) patients specially. Our aim is to verify that whether the Bulpa criteria are the most suitable for diagnosing probable IPA in critically ill COPD patients compared with the other two criteria.
We included critically ill COPD patients admitted to the ICU from April 2006 to August 2013. Patients were classified into four populations: population one (n = 59) comprised all included patients; population two (n = 24) comprised patients with positive mycological findings (both positive cultures and positive serologic tests); population three (n = 18) comprised patients with positive lower respiratory tracts (LRTs) isolation; and population four (n = 5) comprised proven IPA patients with histopathology. Patients in four groups were diagnosed as probable IPA using three criteria respectively, and the "diagnostic rate" of each criteria were compared with each other. Then, the reasons for differences in "diagnostic rate" were analyzed in population two. Finally, the modified Bulpa criteria were proposed.
Bulpa criteria yielded the highest "diagnostic rate" of probable IPA followed by the ICU criteria, while the EORTC/ MSG criteria provided the lowest rates in four populations (the "diagnostic rate" of probable IPA was 33.9%, 16.9% and 6.8% in population one, p = 0.001; 83.3%, 41.7% and 16.7% in population two, p < 0.001; 100%, 55.6% and 22.2% in population three, p < 0.001; 100%, 60% and 20% in population four, p = 0.036). The reasons for the highest "diagnostic rate" by Bulpa criteria were its less strict requirements regarding the doses/courses of steroid use and typical computed tomography (CT) findings. Finally, the modified Bulpa criteria for probable IPA were proposed for critically ill COPD patients admitted to ICU, mainly involving revised interpretations of microbiological findings.
Among the existing three criteria, the Bulpa criteria are the most suitable for diagnosing probable IPA in critically ill COPD patients admitted to ICU. A modified criteria maybe proposed for better diagnosis,and its clinical validity need to be verified in future studies.
已提出三种用于侵袭性肺曲霉病(IPA)诊断的标准,即欧洲癌症研究与治疗组织/ 医学真菌学联合会(EORTC/MSG)标准、布尔帕(Bulpa)标准和重症监护病房(ICU)标准。布尔帕标准是专门为诊断慢性阻塞性肺疾病(COPD)患者的IPA而提出的。我们的目的是验证与其他两个标准相比,布尔帕标准是否最适合诊断重症COPD患者可能的IPA。
我们纳入了2006年4月至2013年8月入住ICU的重症COPD患者。患者被分为四组:第一组(n = 59)包括所有纳入的患者;第二组(n = 24)包括真菌学检查结果阳性的患者(培养和血清学检查均为阳性);第三组(n = 18)包括下呼吸道(LRT)分离阳性的患者;第四组(n = 5)包括经组织病理学证实的IPA患者。分别使用三种标准将四组患者诊断为可能的IPA,并比较每种标准的“诊断率”。然后,在第二组中分析“诊断率”差异的原因。最后,提出了改良的布尔帕标准。
布尔帕标准对可能的IPA的“诊断率”最高,其次是ICU标准,而EORTC/MSG标准在四组中的诊断率最低(第一组中可能的IPA的“诊断率”分别为33.9%、16.9%和6.8%,p = 0.001;第二组中为83.3%、41.7%和16.7%,p < 0.001;第三组中为100%、55.6%和22.2%,p < 0.001;第四组中为100%、60%和20%,p = 0.036)。布尔帕标准“诊断率”最高的原因是其对类固醇使用剂量/疗程和典型计算机断层扫描(CT)表现的要求不太严格。最后,针对入住ICU的重症COPD患者提出了改良的可能IPA的布尔帕标准,主要涉及对微生物学检查结果的修订解释。
在现有的三种标准中,布尔帕标准最适合诊断入住ICU的重症COPD患者可能的IPA。可能需要提出改良标准以更好地进行诊断,其临床有效性需要在未来的研究中得到验证。